Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-05-08
$749.19M
$27.33M
$27.33M
$0.05
$78.3M
$697.73M
$339.43M
N/A
What this quarter tells us
For Q1 FY2026 (ended March 31, 2026), Clover Health reported revenue of $749.2 million, up 62.0% year-over-year. Net income was $27.3 million, a significant improvement from a loss in the prior year, resulting in diluted EPS of $0.05. Operating income also reached $27.3 million, reflecting a strong turnaround. The company had $78.3 million in cash and $339.4 million in equity as of the quarter end.
- •Revenue surged 62.0% YoY to $749.2 million.
- •Net income of $27.3 million, reversing a prior-year loss.
- •Diluted EPS of $0.05, compared to a loss per share in Q1 FY2025.
- •Cash and cash equivalents stood at $78.3 million.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.